Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Aura Biosciences, Inc. (AURA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 49,210,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Aura Biosciences is a clinical-stage biotechnology company using its targeted oncology platform to develop a potential new standard of care across various cancer indications, with an initial focus on ocular and urologic oncology. Co.'s proprietary platform enables the targeting of a range of solid tumors using Virus-Like Particles that can be conjugated with drugs or loaded with nucleic acids to create Virus-Like Drug Conjugates (VDC). AU-011, Co.'s VDC candidate, is being developed for the first line treatment of primary choroidal melanoma. In addition, Co. is developing AU-011 for the treatment of non-muscle invasive bladder cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 70,000 70,000 70,000 1,849,667
Total Buy Value $343,000 $343,000 $343,000 $15,986,162
Total People Bought 2 2 2 3
Total Buy Transactions 2 2 2 9
Total Shares Sold 9,578 52,844 120,103 166,885
Total Sell Value $52,067 $386,113 $1,166,762 $1,563,658
Total People Sold 3 6 7 7
Total Sell Transactions 3 9 14 20
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 81
  Page 1 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Srivastava Sapna   –       •      –    2025-06-17 4 A $0.00 $0 D/D 13,000 23,500     -
   Mattessich Antony C.   –       •      –    2025-06-17 4 A $0.00 $0 D/D 13,000 23,500     -
   Johnson David Michael   –       •      –    2025-06-17 4 A $0.00 $0 D/D 13,000 179,167     -
   Gibney Anthony S See Remarks   •       –      –    2025-06-02 4 A $0.00 $0 D/D 150,000 206,933     -
   De Los Pinos Elisabet See Remarks   •       •      –    2025-06-02 4 D $6.16 $61,280 D/D (9,948) 483,440     -
   De Los Pinos Elisabet See Remarks   •       •      –    2025-06-02 4 OE $5.07 $55,506 D/D 10,948 493,388     -
   Johnson David Michael   –       •      –    2025-05-16 4 B $4.90 $98,000 D/D 20,000 166,167 0.01     -
   Gibney Anthony S See Remarks   •       –      –    2025-05-16 4 S $5.15 $7,823 D/D (1,519) 56,933     -
   Gibney Anthony S See Remarks   •       –      –    2025-05-16 4 B $4.90 $245,000 D/D 50,000 58,452 0.01     -
   Gibney Anthony S See Remarks   •       –      –    2025-05-13 3 IO $0.00 $0 D/D 0 8,452     -
   Elazzouzi Amy Senior Vice President, Finance   •       –      –    2025-04-16 4 S $5.49 $4,925 D/D (897) 81,381     -
   Kilroy Conor See Remarks   •       –      –    2025-04-16 4 S $5.49 $39,319 D/D (7,162) 179,313     -
   Bitetti Teresa Marie   –       •      –    2025-03-31 4 A $0.00 $0 D/D 21,000 21,000     -
   Hopkins Janet Jill Chief Medical Officer   •       –      –    2025-02-18 4 S $7.75 $19,639 D/D (2,534) 269,794     -
   Elazzouzi Amy Senior Vice President, Finance   •       –      –    2025-02-18 4 S $7.75 $10,881 D/D (1,404) 82,278     -
   De Los Pinos Elisabet See Remarks   •       •      –    2025-02-18 4 S $7.75 $156,796 D/D (20,221) 482,440     -
   Plavsic Mark Chief Technology Officer   •       –      –    2025-02-18 4 S $7.75 $16,670 D/D (2,151) 209,456     -
   Plavsic Mark Chief Technology Officer   •       –      –    2025-02-03 4 A $0.00 $0 D/D 90,475 211,607     -
   De Los Pinos Elisabet See Remarks   •       •      –    2025-02-03 4 A $0.00 $0 D/D 194,320 502,661     -
   Elazzouzi Amy Senior Vice President, Finance   •       –      –    2025-02-03 4 A $0.00 $0 D/D 45,240 83,682     -
   Kilroy Conor See Remarks   •       –      –    2025-02-03 4 A $0.00 $0 D/D 90,475 186,475     -
   Hopkins Janet Jill Chief Medical Officer   •       –      –    2025-02-03 4 A $0.00 $0 D/D 120,635 272,328     -
   De Los Pinos Elisabet See Remarks   •       •      –    2025-01-21 4 S $7.67 $122,381 D/D (15,955) 304,692     -
   Elazzouzi Amy Vice President, Finance   •       –      –    2025-01-21 4 S $7.67 $7,679 D/D (1,001) 38,442     -
   De Los Pinos Elisabet See Remarks   •       •      –    2024-10-29 4 S $10.74 $98,788 D/D (9,200) 320,647     -
  81 Records found
  1  2  3  4   
  Page 1 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us